← Back to Search

Effectiveness of an Online Integrated Treatment for Problem Gambling and Tobacco Smoking

N/A
Waitlist Available
Led By Michael Schaub, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up percentage of people at baseline (t0),immediately following the 8-week treatment (t1), and at follow-up (i.e., 24 weeks from baseline, 16 weeks from end of treatment, t2).
Awards & highlights
No Placebo-Only Group

Summary

Research has shown that problem gambling and tobacco smoking are highly comorbid. Problem gamblers who smoke tend to: have more severe gambling problems, experience stronger gambling urges, have other mental disorders, bet larger sums of money, spend more time in gambling activities, and have greater financial problems. Accordingly, it might be helpful to reduce your smoking as well, while you are trying to get a grip on your gambling. Previous studies have treated gambling on its own or tobacco smoking on its own. To date, there has not been a treatment that has targeted treating both at the same time. Considering how often these conditions occur together, it is important to see if combining their treatment results in beneficial outcomes. In the current research, the researchers aim to design and test an online, self-help intervention for co-occurring problem gambling and tobacco smoking. It will draw on strategies from Cognitive Behavioural Therapy (CBT) and Motivational Interviewing (MI) - both which have been shown to be successful in treating problem gambling and tobacco smoking. These outcomes will be compared to a group that receives treatment for problem gambling only. This research will provide insight into a potential new intervention for treating two highly co-occurring conditions.

Eligible Conditions
  • Compulsive gambling

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~percentage of people at baseline (t0),immediately following the 8-week treatment (t1), and at follow-up (i.e., 24 weeks from baseline, 16 weeks from end of treatment, t2).
This trial's timeline: 3 weeks for screening, Varies for treatment, and percentage of people at baseline (t0),immediately following the 8-week treatment (t1), and at follow-up (i.e., 24 weeks from baseline, 16 weeks from end of treatment, t2). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in money spent gambling
Change in number of days gambled
Change in time spent gambling
Secondary study objectives
Cigarette use
Gambling symptom assessment
Nicotine dependence symptoms
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Gambling and Smoking TreatmentExperimental Treatment1 Intervention
Participants in this arm will be given access to the online integrated treatment for gambling and smoking.
Group II: Gambling Only TreatmentActive Control1 Intervention
Participants in this arm will be given access to the online gambling only treatment.

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
621 Previous Clinical Trials
206,263 Total Patients Enrolled
Michael Schaub, PhDPrincipal InvestigatorUniversity of Zurich
Matthew T Keough, PhDPrincipal InvestigatorUniversity of Manitoba
Sherry H Stewart, PhDStudy ChairDalhousie University
James Mackillop, PhDStudy ChairMcMaster University
David Hodgins, PhDStudy ChairUniversity of Calgary
1 Previous Clinical Trials
R. Michael Bagby, PhDStudy ChairUniversity of Toronto
1 Previous Clinical Trials
72 Total Patients Enrolled
~41 spots leftby Jan 2026